ICAM1 and neoplasm: We suspect that cytokine-induced ICAM-1 overexpression is a reason for the onset of toxicity mediated by the high affinity CAR T cells, as demonstrated by the lack of apparent toxicity following TM CAR T treatment in non-tumor bearing animals.